We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation

    Aims

    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for hematological malignancies. However, viral...

    Xun-Hong Cao, Ze-Ying Fan, ... **ang-Yu Zhao in Journal of Translational Medicine
    Article Open access 06 March 2024
  2. MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation

    Autologous hematopoietic stem cell transplantation (AHSCT) remains the most prevalent type of stem cell transplantation. In our study, we...

    Damian Mikulski, Mateusz Nowicki, ... Wojciech Fendler in Biomarker Research
    Article Open access 23 April 2024
  3. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years

    Autologous(auto-) and allogeneic(allo-) hematopoietic stem cell transplantation (HSCT) are key treatments for relapsed/refractory diffuse large...

    Philipp Berning, Mathilde Fekom, ... Norbert Schmitz in Blood Cancer Journal
    Article Open access 05 July 2024
  4. Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts

    Hematopoietic stem cell (HSC) graft manipulations comprise immunologic laboratory techniques designed for negative selection (i.e., reduction of...
    Tahereh Rostami, Saeed Mohammadi, Azadeh Kiumarsi in Cancer Treatment: An Interdisciplinary Approach
    Chapter 2023
  5. Effect of Hematopoietic Stem Cell Transplantation and Post-Transplantation Cyclophosphamide on the Microglia Phenotype in Rats with Experimental Allergic Encephalomyelitis

    Microglia are the resident immune cells of the central nervous system, playing a role in the inflammatory process development and resolution,...

    Kaja Kasarełło, Martyna Seta, ... Agnieszka Cudnoch-Jędrzejewska in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 24 March 2023
  6. In Vivo Modeling of Leukemia by Murine Stem Cell Transplantation

    Murine stem cell transplantation is a well-established method for the in vivo study of leukemic pathophysiology. Adoptive transfer of murine leukemic...
    Leo Edlinger in Mouse Models of Cancer
    Protocol 2024
  7. Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation

    Background

    The prognostic significance of myelofibrosis (MF) grade in patients with myelodysplastic syndrome (MDS) following an allogeneic...

    Panpan Zhu, **aoyu Lai, ... Yi Luo in Journal of Translational Medicine
    Article Open access 13 March 2024
  8. Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation

    Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). Although most patients...

    Oren Pasvolsky, Zhongya Wang, ... Muzaffar H. Qazilbash in Blood Cancer Journal
    Article Open access 17 May 2024
  9. Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

    Primary induction failure (PIF) in acute myeloid leukemia (AML) patients is associated with poor outcome, with allogeneic hematopoietic stem cell...

    Miriam Mozaffari Jovein, Gabriele Ihorst, ... Florian Scherer in Blood Cancer Journal
    Article Open access 10 December 2023
  10. Hematopoietic Stem Cell Development in Mammalian Embryos

    Hematopoietic stem cells (HSCs) are situated at the top of the adult hematopoietic hierarchy in mammals and give rise to the majority of blood cells...
    Siyuan Hou, Chen Liu, ... Yu Lan in Hematopoietic Stem Cells
    Chapter 2023
  11. Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation

    Purpose

    To establish the population pharmacokinetics (PPK) model of cyclosporine A(CsA) in pediatric patients with thalassemia undergoing allogeneic...

    Rongda Cai, Limin Zhang, ... Taotao Liu in European Journal of Clinical Pharmacology
    Article 08 February 2024
  12. E3 ubiquitin ligase on the biological properties of hematopoietic stem cell

    Hematopoietic stem cells are a group of heterogeneity cells with the potential to differentiate into various types of mature blood cells. Their basic...

    Qianru Zhan, **g Wang, ... Lijun Zhang in Journal of Molecular Medicine
    Article Open access 21 April 2023
  13. Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay

    The aim of this study was to evaluate the prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation...

    Victor A C Castro-Lima, Ana Paula T Santos, ... Silvia F Costa in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 May 2023
  14. Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

    The burden of CMV infection and disease is important in pediatric hematopoietic stem cell transplantation (HSCT), notably in the subgroup of patients...

    Thibaut César, Minh P. Le, ... Bénédicte Neven in Journal of Clinical Immunology
    Article 20 December 2023
  15. Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation

    Microbiota are essential to normal immune development and there is growing recognition of its importance to human health and disease and deepening...

    Matthew J. Pianko, Jonathan L. Golob in Cancer and Metastasis Reviews
    Article 29 April 2022
  16. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation

    Background

    Severe pneumonia is one of the most important causes of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT)....

    Yuewen Wang, **aohui Zhang, ... **aodong Mo in Virology Journal
    Article Open access 14 May 2024
  17. MicroRNA-125b as a valuable predictive marker for outcome after autologous hematopoietic stem cell transplantation

    Background

    Relapse is a frequent occurrence in autologous hematopoietic stem cell transplantation (AHSCT), and early relapse after AHSCT results in...

    Mohammad Rafiee, Fatemeh Amiri, ... Abbas Hajifathali in BMC Cancer
    Article Open access 03 March 2023
  18. Lineage tracking to reveal the fate of hematopoietic stem cells influenced by Flk2 multipotent progenitors after transplantation

    After transplantation, hematopoietic stem cells (HSCs) sustain blood cell regeneration throughout the patient’s life. Recent studies suggest that...

    Zheng Wang, Du Jiang, ... Rong Lu in Experimental & Molecular Medicine
    Article Open access 13 January 2023
  19. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial

    Acute graft-versus-host disease (aGVHD) of the lower gastrointestinal (GI) tract is a major cause of morbidity and mortality in patients receiving...

    Yi-Bin Chen, Mohamad Mohty, ... Yngvar Fløisand in Nature Medicine
    Article Open access 06 June 2024
  20. Prevalence and Characteristics of Non-tuberculous Mycobacteria (NTM) Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-analysis

    Purpose

    Non-tuberculous mycobacteria (NTM) infections in hematopoietic stem cell transplantation (HSCT) recipients represent a diagnostic and...

    Bianca Laura Cinicola, Giorgio Ottaviano, ... Reem Elfeky in Journal of Clinical Immunology
    Article Open access 22 December 2023
Did you find what you were looking for? Share feedback.